Portuguese 
English 
Spanish 
3 min of reading 
7 comments 
Novo Nordisk’s Investment in Montes Claros Will Create Many Jobs at Its Factory and Expand the Production of Enzymes for Medications.
The Government of Minas has announced the expansion of an enzyme factory in Montes Claros, in Northern Minas. Novo Nordisk, a Danish pharmaceutical company, will invest R$ 500 million to increase the production of enzymes, such as enterokinase and ALP, essential for the manufacturing of medications like insulin. With the expansion, 400 new jobs will be created, in addition to strengthening the factory’s production and meeting the growing global demand for medications.
The Expansion of the Factory and the Generation of New Jobs
The Governor of Minas Gerais, Romeu Zema, celebrated the investment, highlighting the importance of the factory’s expansion for the growth of the local economy and the creation of more jobs.
The expansion of the factory will be crucial for Montes Claros, which will become a strategic hub in the production of enzymes and medications in Brazil and worldwide.
-
BYD produces up to 4,400 cars per day and one vehicle every 20 seconds at its largest factory in Xi’an, surpasses Tesla in industrial pace, leaves Volkswagen far behind in pure electric vehicles, and consolidates China as the birthplace of the world’s largest electric car manufacturer.
-
While cities suffocate with smoke and fields burn worthless straw, India transforms sugarcane bagasse, non-recyclable plastic, and agricultural residue into bricks to build cheaper rural housing.
-
With 50 tons of plastic waste, a 30-meter bridge was assembled over a river in Scotland. It seems like an ordinary construction, but it doesn’t use traditional wood or steel and can even be disassembled.
-
Without concrete, without traditional cleaning, and without common separation, a block made of recycled plastic transforms problematic waste into a rigid piece for walls and structures.
Zema emphasized that the factory’s expansion will bring not only new jobs but also a significant contribution to increasing exports and strengthening the local economy.
With the expansion of the enzyme factory, Novo Nordisk will contribute to the creation of approximately 400 indirect jobs, in addition to 40 direct jobs.
The enzyme factory in Montes Claros, with its production focused on insulin and other medications, will be an important engine for the local job market.
The government of Minas Gerais believes that the expansion of the enzyme factory will bring great benefits not only to the city but also to the region, generating new jobs and strengthening the economy of Northern Minas.
The Secretary of State for Economic Development, Fernando Passalio, commented on the positive impact that the factory’s expansion will have on job creation.
He highlighted that, through strategic efforts, the investment was secured, with the enzyme factory representing a great opportunity for Montes Claros to solidify itself as an important hub in medication production, in addition to creating more jobs.
The Role of Enzymes in Medication Production
The production of enzymes such as enterokinase and ALP will be expanded with the factory’s enlargement. These enzymes are essential for the production of medications, such as insulin, that treat chronic diseases like diabetes and obesity.
The enzyme factory in Montes Claros plays a crucial role in supplying these enzymes to the global market, and the expansion will further increase production capacity to meet the growing demand.
Reinaldo Costa, corporate vice president of Novo Nordisk in Montes Claros, explained that the factory’s expansion will help the company increase the production of medications.
“With the increase in enzyme production, we will be able to meet the growing demand for innovative treatments and save more lives,” he stated.
The enzyme factory in Montes Claros will, therefore, be a fundamental element in the process of expanding the production of essential medications for various diseases.
The expansion of the enzyme factory in Montes Claros will bring benefits not only for medication production but also for job creation.
The enlargement of the enzyme factory will be a milestone for the city, with the creation of new jobs and the strengthening of the local pharmaceutical sector.
Montes Claros, with the increase in enzyme and medication production, will establish itself as an important center of production and innovation in Brazil.
The investment of R$ 500 million will allow Novo Nordisk to significantly expand the factory’s capacity and create new job opportunities for the local population.
Tem vaga para estagiário, na função, de emgenharia de computação, ou em automação?
Emgenharia estudou na selva
Uai só o mineirinho tá querendo trabalhar nesse trem.
Montador eletrônico,